Open access
Jul 2026
CXCL2 is a modifiable driver of sarcopenic inflammation attenuated by exercise in older women: Integrated transcriptomic and experimental evidence.
Human evidence from year-long clinical exercise interventions identified CXCL2 as a modifiable inflammatory mediator linking aging to muscle atrophy and highlights the CXCL2-CXCR2 axis as a promising target for mitigating sarcopenia.
Juyeon Lee, Sung-Wook Chun, Su-Bin Choi et al.
· Journal of Sport and Health... · 0 citations